These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33982243)

  • 1. Correlation Between Anthropometric Measurements and Non-alcoholic Fatty Liver Disease in Individuals With Obesity Undergoing Bariatric Surgery: Cross-Sectional Study.
    Reis SS; Callejas GH; Marques RA; Gestic MA; Utrini MP; Chaim FDM; Ramos AC; Chaim EA; Cazzo E
    Obes Surg; 2021 Aug; 31(8):3675-3685. PubMed ID: 33982243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Predictors of Non-alcoholic Steatohepatitis and Its Severity in Individuals Undergoing Bariatric Surgery.
    Ayres ABS; Carneiro CRG; Gestic MA; Utrini MP; Chaim FDM; Callejas-Neto F; Chaim EA; Cazzo E
    Obes Surg; 2024 Feb; 34(2):456-466. PubMed ID: 38097891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Factors Associated with Hepatic Iron Overload in Obese Individuals Undergoing Bariatric Surgery: a Cross-Sectional Study.
    Jesus RN; Callejas GH; Concon MM; Braga JGR; Marques RA; Chaim FDM; Gestic MA; Utrini MP; Ramos AC; Chaim EA; Cazzo E
    Obes Surg; 2020 Dec; 30(12):4967-4973. PubMed ID: 32979184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Histopathological and Biochemical Aspects of NAFLD With the Severity of Liver Fibrosis in Individuals With Obesity: Cross-sectional Study.
    Carneiro CRG; Ayres ABS; Gestic MA; Utrini MP; Chaim FDM; Callejas-Neto F; Chaim EA; Cazzo E
    Obes Surg; 2024 May; 34(5):1569-1574. PubMed ID: 38502518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvesicular Steatosis in Individuals with Obesity: a Histological Marker of Non-alcoholic Fatty Liver Disease Severity.
    Germano CW; Mega PF; Mattosinho TJAP; Dias LLC; Gestic MA; Utrini MP; Chaim FDM; Callejas-Neto F; Chaim EA; Cazzo E
    Obes Surg; 2023 Mar; 33(3):813-820. PubMed ID: 36694089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Non-alcoholic Fatty Liver Disease and Steatohepatitis Risk Factors in Patients Undergoing Bariatric Surgery.
    Morita S; Neto Dde S; Morita FH; Morita NK; Lobo SM
    Obes Surg; 2015 Dec; 25(12):2335-43. PubMed ID: 25920616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Scores Assessing Histological Activity and Estimated Long-Term Risk Analysis of Hepatic Decompensation of Non-Alcoholic Fatty Liver Disease in Individuals Undergoing Bariatric Surgery.
    Hatto M; Ivano VK; Gestic MA; Utrini MP; Chaim FDM; Callejas-Neto F; Chaim EA; Cazzo E
    Obes Surg; 2023 May; 33(5):1580-1586. PubMed ID: 37004688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Alcoholic Fatty Liver Disease Is Associated with Impairment of Ejection Fraction Among Individuals with Obesity Undergoing Bariatric Surgery: Results of a Cross-Sectional Study.
    de Freitas Diniz TB; de Jesus RN; Jimenez LS; Pareja JC; Chaim EA; Cazzo E
    Obes Surg; 2020 Feb; 30(2):456-460. PubMed ID: 31529394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of anthropometric indices for the screening of nonalcoholic fatty liver disease in pre- and postmenopausal women.
    Hong SH; Hwang SY; Kim JA; Lee YB; Roh E; Kim NH; Seo JA; Kim SG; Kim NH; Choi KM; Baik SH; Yoo HJ
    Menopause; 2020 Jan; 27(1):88-94. PubMed ID: 31613826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CORRELATION BETWEEN NONALCOHOLIC FATTY LIVER DISEASE FEATURES AND LEVELS OF ADIPOKINES AND INFLAMMATORY CYTOKINES AMONG MORBIDLY OBESE INDIVIDUALS.
    Baltieri L; Chaim EA; Chaim FDM; Utrini MP; Gestic MA; Cazzo E
    Arq Gastroenterol; 2018; 55(3):247-251. PubMed ID: 30540086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 Diabetes Mellitus and Simple Glucose Metabolism Parameters may Reliably Predict Nonalcoholic Fatty Liver Disease Features.
    Cazzo E; Jimenez LS; Gestic MA; Utrini MP; Chaim FHM; Chaim FDM; Pareja JC; Chaim EA
    Obes Surg; 2018 Jan; 28(1):187-194. PubMed ID: 28741239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DIAGNOSTIC ACCURACY OF THE NON-INVASIVE MARKERS NFLS, NI-NASH-DS, AND FIB-4 FOR ASSESSMENT OF DIFFERENT ASPECTS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN INDIVIDUALS WITH OBESITY: CROSS-SECTIONAL STUDY.
    Haddad GM; Gestic MA; Utrini MP; Chaim FDM; Chaim EA; Cazzo E
    Arq Gastroenterol; 2024; 61():e23050. PubMed ID: 38896571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.
    Seki Y; Kakizaki S; Horiguchi N; Hashizume H; Tojima H; Yamazaki Y; Sato K; Kusano M; Yamada M; Kasama K
    J Gastroenterol; 2016 Mar; 51(3):281-9. PubMed ID: 26314837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body mass index and the visceral adipose tissue expression of IL-6 and TNF-alpha are associated with the morphological severity of non-alcoholic fatty liver disease in individuals with class III obesity.
    Jorge ASB; Andrade JMO; Paraíso AF; Jorge GCB; Silveira CM; de Souza LR; Santos EP; Guimaraes ALS; Santos SHS; De-Paula AMB
    Obes Res Clin Pract; 2018; 12(Suppl 2):1-8. PubMed ID: 27083404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease.
    Kuang M; Sheng G; Hu C; Lu S; Peng N; Zou Y
    Lipids Health Dis; 2022 Oct; 21(1):104. PubMed ID: 36266655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of neck circumference-related indices with metabolic, atherogenic and liver function biomarkers in patients with non-alcoholic fatty liver disease: a cross-sectional study.
    Arefhosseini S; Tutunchi H; Tavakkoli S; Arefhosseini SR; Ebrahimi-Mameghani M
    BMJ Open; 2023 Sep; 13(9):e073452. PubMed ID: 37699622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Helicobacter pylori infection associated with non-alcoholic fatty liver disease in individuals undergoing bariatric surgery? Cross-sectional study.
    Valadares EC; Gestic MA; Utrini MP; Chaim FDM; Chaim EA; Cazzo E
    Sao Paulo Med J; 2023; 141(5):e2022517. PubMed ID: 37042863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic Fatty Liver Disease in Morbidly Obese Individuals Undergoing Bariatric Surgery: Prevalence and Effect of the Pre-Bariatric Very Low Calorie Diet.
    Schwenger KJP; Fischer SE; Jackson TD; Okrainec A; Allard JP
    Obes Surg; 2018 Apr; 28(4):1109-1116. PubMed ID: 29098545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Results of Bariatric Surgery for Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis Treatment in Morbidly Obese Japanese Patients.
    Uehara D; Seki Y; Kakizaki S; Horiguchi N; Tojima H; Yamazaki Y; Sato K; Yamada M; Uraoka T; Kasama K
    Obes Surg; 2019 Apr; 29(4):1195-1201. PubMed ID: 30542827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?
    Machado MV; Policarpo S; Coutinho J; Carvalhana S; Leitão J; Carvalho A; Silva AP; Velasco F; Medeiros I; Alves AC; Bourbon M; Cortez-Pinto H
    Obes Surg; 2020 Feb; 30(2):560-568. PubMed ID: 31637670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.